), helps to clarify why KIF15 is able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by each of those mitotic motors was arrested only once they ended up separately inhibited, lending assist to the proposal that a mix drug therapy targeting these motors may be a workable tacti